Form 4: Entera Bio Ltd. Executive Hillel Galitzer Reports Stock and Option Awards

Hillel Galitzer, Chief Operating Officer of Entera Bio Ltd., reports the acquisition of restricted stock units and stock options.

Summary

• Hillel Galitzer, the Chief Operating Officer of Entera Bio Ltd., filed a Form 4 detailing changes in beneficial ownership.
• On April 28, 2025, Galitzer acquired 26,316 ordinary shares through a grant of stock-settled restricted stock units at a price of $0.
• These restricted stock units vest ratably on a quarterly basis over one year, starting April 28, 2025.
• Galitzer also acquired options to purchase 100,000 ordinary shares at an exercise price of $2.28.
• 33% of these options vest on April 28, 2025, with the remainder vesting ratably on a quarterly basis over the following three years.

Sentiment

Score: 7

Explanation: The document reflects a standard executive compensation practice, which is generally viewed neutrally to positively as it aligns management interests with shareholders. The vesting schedules suggest a long-term commitment.

Positives

• The grant of stock options and restricted stock units to the COO aligns his interests with those of the shareholders.
• The vesting schedules encourage long-term commitment from the executive.

Industry Context

Stock option and RSU grants are a common practice in the biotech industry to incentivize executives and align their interests with shareholders.

Comparison to Industry Standards

• Stock option grants are a standard component of executive compensation packages in the biotechnology industry.
• Vesting schedules, such as the three-year vesting period for the options, are typical to ensure long-term commitment.
• Comparable companies often use similar equity-based compensation to attract and retain key personnel.

Stakeholder Impact

• The grants incentivize the COO to improve company performance, potentially benefiting shareholders.
• Employees may be indirectly impacted by the COO's increased motivation.

Key Dates

Keywords

Form 4, Beneficial Ownership, Stock Options, Restricted Stock Units, Entera Bio, ENTX, Hillel Galitzer, COO